 
Today, the U.S. Food and Drug Administration (FDA) is providing updated information about medical device reports that the FDA received from November 1, 2022, to December 31, 2022, and are reportedly associated with the breakdown or suspected breakdown of the polyester-based polyurethane (PE-PUR) foam used in the Philips Respironics ventilators, BiPAP machines, and CPAP machines included in the recall announced in June 2021.
Since April 2021, the FDA has received more than 98,000 medical device reports, including 346 reports of death, reportedly associated with the PE-PUR foam breakdown or suspected foam breakdown. The FDA will continue to update the public about the status of the Philips Respironics’ recall announced in June 2021.
Sign up to recieve email alerts
Subscribe to Philips CPAP, BiPAP, and Ventilator Recall email list for new or updated content that is specifically related to the Philips CPAP, BiPAP, and Ventilator Recall.
Questions?
The FDA.gov website includes FAQs on Philips Respironics Ventilator, BiPAP Machine, and CPAP Machine Recalls to address questions about the recalls and provide additional resources with more information.
|
